The Food and Drug Administration (FDA) has not approved any over-the-counter (OTC) or CBD consumer products and has only approved a prescription drug called Epidiolex, which is used to treat seizures associated with certain forms of epilepsy and tuberous sclerosis. complex, a rare genetic disease.
In fact, the FDA has issued warning letters to several CBD manufacturers, finding that many products do not contain the CBD levels listed on their labels. The letters also addressed the companies’ illegal claims that their CBD products can prevent, diagnose, alleviate, treat or cure certain diseases, as well as their marketing CBD products as dietary supplements.
Given these FDA warnings, consumers can take certain steps to make sure they are using CBD as safely as possible. Most of the potential benefits of CBD are based primarily on anecdotal reports because human clinical data are limited, says Dr. Chen, who stresses the importance of the CBD dose.
“Most consumers take less than 100 milligrams of CBD a day, and while the effectiveness of CBD in this dose range has not been well studied, CBD appears to be safe at the recommended serving sizes for most consumer products manufacturers, “he says. . The risk is low, but possible side effects of CBD at these lower doses may include diarrhea and lethargy, he adds.
“Generally, my advice for dosing any product is to find the lowest dose that is effective and does not cause intolerable side effects,” says Dr. Chen. “Consumers should start with a low dose and gradually increase it, paying close attention to the possible effectiveness and side effects.”
CBD can also interact with certain drugs, including antidepressants, antipsychotics, and opioids, which can cause adverse or side effects.
“Consumers should avoid taking CBD with medications that carry a grapefruit warning, such as certain anticoagulants and anticonvulsant medications, as CBD and grapefruit interact with similar medications,” says Dr. Chen. “CBD should also be avoided by anyone with liver disease or during pregnancy.”
Consumers can go one step further by researching individual CBD products by checking the Certificate of Analysis (COA) of the batch number of that particular CBD product. If the manufacturer provides access to the product COA, it may be posted on its website.
The COA lists what a CBD product contains based on an analysis performed by a third-party lab. In general, COA includes the concentration of hemp extract, the percentage of THC and other cannabinoids and whether the product contains yeasts, molds, bacteria, pesticides or residual solvents.
Because the FDA has only approved one prescription product that contains CBD, most health care providers have minimal formal education about CBD, says Dr. Chen. However, many holistic health professionals, such as naturopaths, have experience with CBD and its effects on their clients.
“There are” cannabis clinics “in states that have legalized cannabis that have received additional training and / or have significant experience in monitoring cannabis use in their patients, including the use of CBD,” he says. “You can find these doctors through organizations like the Society of Cannabis Clinicians.”
Chewable CBD jelly beans
One container contains an amount of 30 jelly beans, with each individual serving containing a 10 mg dose of pure and THC-free CBD isolate.
Forbes Health covers CBD and cannabis products in accordance with FTC guidelines. Learn more about Forbes Health practices and policies as to how we cover CBD and cannabis as an editor.